Beverly Hills, CA, Aug. 31, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Crown Baus Capital Corporation (OTC: CBCA), a global acquisition-based conglomerate with investments primarily in five industries – High-Tech Incubation, Drug Development, Entertainment & Media, Education, and Financial Services – is pleased to announce that the Company’s growth strategy for 2018 is being implemented successfully and that current market dynamics are favorable for CBCA’s portfolio companies.

“Crown Baus Capital specializes in the vertical integration of industrial, commercial, and retail profit centers, along with partnerships and start-ups, to create operational efficiencies and increased value to our shareholders,” stated Mr. Raymond C. Dabney, CBCA’s President, Chief Executive Officer (CEO), and Co-founder. “One of our major deals so far this year was the acquisition of a 100% stake in Cannabia®, the world’s first alcoholic, cannabis beer. The acquisition of Cannabia® is strategically important to the growth strategy of CBCA and our partners, and more acquisitions are planned.”

Cannabia® sales have been growing 15 to 25% per year, and CBCA expects beverage sales to increase substantially as the Company introduces Cannabia® products into the U.S. and Canadian markets through new distribution deals and brewery partnerships.

“This is an exciting time for this market segment,” stated Mr. Dabney. “Molson Coors Canada recently announced a deal with The Hydropothecary Corporation, a leading Canadian cannabis producer, to jointly develop cannabis-infused, non-alcoholic beverages for the Canadian market. I believe this type of investment validates CBCA’s decision to acquire Cannabia®, and demonstrates the interest in, and potential for, cannabis-infused beverages. I anticipate significant growth for the Cannabia® brand in the U.S. and throughout Europe.” 

Molson Coors Canada is the Canadian business unit of Molson Coors Brewing, a company with 2017 revenue of approximately $11 billion. 

Cannabia’s® first hemp beverage, a cannabis beer, was launched in March 1996 when Germany officially authorized the cultivation of hemp, the so-called “fiber hemp”. A secret, hand-selected blend of organic barley malt, hops, and hemp give Cannabia® its rich taste and unmistakable hemp aroma. Cannabia® is currently distributed in several European Union countries, as well as in a number of important markets, including Switzerland, Japan, South Korea, and India. 

Cannabía® is brewed in Germany partially as a traditional organic "Pils", a lager-beer, and in a second step, a secret special organic hemp. Source water and an organic sugar blend are added before fermentation has ended. This yields a healthy beer and hemp-mixed beverage after several weeks of fermentation and maturation. Other beverages produced include alcohol-free Cannabia (coming soon), Canna Cola (THC-Free), and The 4 Elements® Organic German Premium beer. 

For more information on Cannabia®, please visit:

http://www.cannabia.de/

In addition to the Molson Coors Brewing deal, there have been a number of recent transactions that further signal the tremendous growth potential of the market for cannabis-infused beverages. Tilray Canada Limited, a subsidiary of Tilray, Inc. announced that it has been selected by the Nova Scotia Liquor Corporation to receive an initial purchase order for adult-use cannabis. 

Constellation Brands, known for beverages such as Corona, Pacifico, Modelo,  and Robert Mondavi, recently expanded its partnership with Canopy Growth Corporation, a diversified cannabis company. As a result of Constellations new investment, Canopy Growth will have proceeds of approximately $4 billion. 

Additionally, there is the startup company, Ceria, founded by the creator of Blue Moon, Keith Villa. Ceria intends to create custom and cannabis-infused, non-alcoholic craft beer.

“Cannabia® is just one of a number of exciting deals for CBCA in 2018,” stated Mr. Dabney. “Our pipeline of opportunities includes the opening of a new media production studio in Burbank, CA to provide a platform for our production, artist management, distribution, events and concerts, finance, and other related initiatives; the launch of a new technology company; and several real estate deals that will be announced shortly. I expect this year to be a tremendously rewarding year for CBCA, our shareholders, and our stakeholders.”

About Crown Baus Capital Corporation

Crown Baus Capital Corporation is a global acquisition-based conglomerate targeting five primary industries: High-Tech Incubation, Drug Development, Entertainment & Media, Education, and Financial Services. The Company specializes in the vertical integration of industrial, commercial, and retail profit centers, along with partnerships and start-ups, to create synergistic savings and increased value to our shareholders.

Forward-Looking Statements

This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing words such as “anticipate,” “seek,” intend,” “believe,” “estimate,” “expect,” “project,” “plan,” or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition. Crown Baus Capital Corporation does not undertake any duty nor does it intend to update the results of these forward-looking statements. Safe Harbor Statement. The Private Securities Litigation Reform Act of 1995 provides a ‘safe harbor’ for forward looking statements. Certain of the statements contained herein, which are not historical facts are forward looking statements with respect to events, the occurrence of which involved risks and uncertainties. These forward-looking statements may be impacted, either positively or negatively, by various factors. Information concerning potential factors that could affect the company is detailed from time to time in the company’s reports filed with the Securities and Exchange Commission.

Attachment

Crown Baus Capital Corporation Raymond C. Dabney President & CEO, Co-Founder C: +1 (310) 650-3788 T: +1 (888) 263-0948 info@crownbaus.com